BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 23087000)

  • 1. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.
    Friedmann-Morvinski D; Bushong EA; Ke E; Soda Y; Marumoto T; Singer O; Ellisman MH; Verma IM
    Science; 2012 Nov; 338(6110):1080-4. PubMed ID: 23087000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.
    Jacques TS; Swales A; Brzozowski MJ; Henriquez NV; Linehan JM; Mirzadeh Z; O' Malley C; Naumann H; Alvarez-Buylla A; Brandner S
    EMBO J; 2010 Jan; 29(1):222-35. PubMed ID: 19927122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma.
    Ghazi SO; Stark M; Zhao Z; Mobley BC; Munden A; Hover L; Abel TW
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):729-40. PubMed ID: 22805776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
    Di K; Linskey ME; Bota DA
    Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entry.
    Tchorz JS; Tome M; Cloëtta D; Sivasankaran B; Grzmil M; Huber RM; Rutz-Schatzmann F; Kirchhoff F; Schaeren-Wiemers N; Gassmann M; Hemmings BA; Merlo A; Bettler B
    Cell Death Dis; 2012 Jun; 3(6):e325. PubMed ID: 22717580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tumor stem cells.
    Xie Z
    Neurochem Res; 2009 Dec; 34(12):2055-66. PubMed ID: 19856100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP2 promotes neural stem cell maintenance and proliferation differentially associated with glioblastoma subtypes.
    Shen F; Song C; Liu Y; Zhang J; Wei Song S
    Brain Res; 2019 Feb; 1704():174-186. PubMed ID: 30347220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models.
    Irvin DM; McNeill RS; Bash RE; Miller CR
    Brain Pathol; 2017 Jan; 27(1):36-50. PubMed ID: 26762242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
    Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
    Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
    Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.
    Lee HK; Bier A; Cazacu S; Finniss S; Xiang C; Twito H; Poisson LM; Mikkelsen T; Slavin S; Jacoby E; Yalon M; Toren A; Rempel SA; Brodie C
    PLoS One; 2013; 8(2):e54652. PubMed ID: 23390502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosaic analysis with double markers reveals tumor cell of origin in glioma.
    Liu C; Sage JC; Miller MR; Verhaak RG; Hippenmeyer S; Vogel H; Foreman O; Bronson RT; Nishiyama A; Luo L; Zong H
    Cell; 2011 Jul; 146(2):209-21. PubMed ID: 21737130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
    Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
    Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation Promotes a Conversion of Astrocytes into Neural Progenitor Cells via NF-κB Activation.
    Gabel S; Koncina E; Dorban G; Heurtaux T; Birck C; Glaab E; Michelucci A; Heuschling P; Grandbarbe L
    Mol Neurobiol; 2016 Oct; 53(8):5041-55. PubMed ID: 26381429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin: a marker for reactive gliosis in gliomas and brain injury.
    Kolar K; Freitas-Andrade M; Bechberger JF; Krishnan H; Goldberg GS; Naus CC; Sin WC
    J Neuropathol Exp Neurol; 2015 Jan; 74(1):64-74. PubMed ID: 25470350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Glioma with Human Embryonic Stem Cell-Derived Neural Lineages.
    Modrek AS; Prado J; Bready D; Dhaliwal J; Golub D; Placantonakis DG
    Methods Mol Biol; 2018; 1741():227-237. PubMed ID: 29392705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term culture and differentiation of human glioma stem cells ].
    Yang LY; Wang CY; Zheng JK; Wen JC; Li WY; Huang XP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):141-4. PubMed ID: 16468664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
    Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
    J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.